Clinical Trials on Prevention of Venous Thromboembolism After Knee Arthroplasty in Finland
Total 5 results
-
Boehringer IngelheimCompletedArthroplasty, Replacement | Prevention of Venous Thromboembolism | Moderate Renal Impairment (CrCl 30-50 mL/Min)Austria, Canada, Czechia, Finland, Netherlands, Sweden
-
Boehringer IngelheimCompletedThromboembolism | Arthroplasty, Replacement, KneeUnited States, Canada, Mexico, United Kingdom
-
Boehringer IngelheimCompletedThromboembolism | Arthroplasty, Replacement, HipAustralia, Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, South Africa, Spain, Sweden
-
Astellas Pharma Europe B.V.CompletedVenous Thromboembolism | Arthroplasty, Replacement, HipDenmark, Spain, United States, Austria, Colombia, Russian Federation, India, Italy, United Kingdom, Germany, Hungary, Estonia, Romania, South Africa, Israel, Poland, Sweden, Canada, Australia, Lithuania, Ukraine, Latvia, Finland, Brazil, Slovak... and more
-
Boehringer IngelheimCompletedThromboembolism | Arthroplasty, Replacement, KneeAustralia, Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, Netherlands, Poland, South Africa, Spain, Sweden